- Home
- HMST vs STXS Comparison
HMST vs STXS Comparison
Compare HMST & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- STXS
- Stock Information
- Founded
- HMST 1921
- STXS 1990
- Country
- HMST United States
- STXS United States
- Employees
- HMST N/A
- STXS N/A
- Industry
- HMST Major Banks
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HMST Finance
- STXS Health Care
- Exchange
- HMST Nasdaq
- STXS Nasdaq
- Market Cap
- HMST 263.0M
- STXS 261.1M
- IPO Year
- HMST 2012
- STXS 2004
- Fundamental
- Price
- HMST N/A
- STXS $2.85
- Analyst Decision
- HMST Hold
- STXS
- Analyst Count
- HMST 3
- STXS 0
- Target Price
- HMST $14.17
- STXS N/A
- AVG Volume (30 Days)
- HMST 148.5K
- STXS 395.1K
- Earning Date
- HMST 10-28-2025
- STXS 11-10-2025
- Dividend Yield
- HMST N/A
- STXS N/A
- EPS Growth
- HMST N/A
- STXS N/A
- EPS
- HMST N/A
- STXS N/A
- Revenue
- HMST $78,496,000.00
- STXS $31,806,000.00
- Revenue This Year
- HMST $157.89
- STXS $30.92
- Revenue Next Year
- HMST $8.65
- STXS $43.27
- P/E Ratio
- HMST N/A
- STXS N/A
- Revenue Growth
- HMST N/A
- STXS 33.94
- 52 Week Low
- HMST $8.41
- STXS $1.54
- 52 Week High
- HMST $16.10
- STXS $3.05
- Technical
- Relative Strength Index (RSI)
- HMST 8.91
- STXS 56.73
- Support Level
- HMST $13.54
- STXS $2.81
- Resistance Level
- HMST $14.58
- STXS $2.92
- Average True Range (ATR)
- HMST 0.29
- STXS 0.11
- MACD
- HMST -1.30
- STXS -0.01
- Stochastic Oscillator
- HMST 0.00
- STXS 62.07
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.